JZJoana Maira Valentini Zacarias

Joana Maira Valentini Zacarias

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joana Maira Valentini Zacarias has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • High‐Resolution HLA Allele and Haplotype Frequencies in a Southern Brazilian Population

    by Ana Paula Sokolowski de Lima, Matheus Braga, Kayo Thiago Ribeiro Perroni, Julyane Schavaren, Laura Vitória Perocco, Mariana de Souza Terron, Fernanda Pelisson Massi, Larissa Danielle Bahls Pinto, Bruna Karina Banin Hirata, Quirino Alves de Lima Neto, et al.

    The HLA system has been extensively studied due to its crucial role in the immune system, as well as its application in population, anthropological and epidemiological research. This study analysed 11 loci of HLA allele and haplotype frequency (HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQA1, ‐DQB1, ‐DPA1, ‐DPB1 and ‐DRB3/4/5) using high‐resolution next‐generation sequencing technology. A total of 5287 volunteer bone marrow donors from the Northwestern region of the state of Paraná, in Southern Brazil, were rated. Most of the analysed loci were in Hardy–Weinberg equilibrium, except for HLA‐DPA1 and ‐DPB1. The most frequent alleles were HLA‐A*02:01:01 , HLA‐B*51:01:01 and HLA‐C*04:01:01 for Class I and DRB1*07:01:01 , DRB3*02:02P , DRB4*01:01P , DRB5*01:01P , DQA1*01:02:01 , DQB1*05:01:01 , DPA1*01:03:01 and DPB1*04:01:01 for Class II. The most prevalent haplotype for ABCDRB1 alleles was HLA‐A*01:01:01 ~ B*08:01:01 ~ C*07:01:01 ~ DRB1*03:01:01 , which is typical of European descents. These results reflect a predominantly European genetic contribution, with additional African and Native American influences. These data extend understanding of genetic diversity about the Brazilian HLA system and provide information to characterise this population's HLA profile.

    • 16 February 2026
      • Vol. 59, e14750
    Open Access

    Perinatal and laboratory determinants of fortified human milk use: a case-control study.

    by C B G Tavares, J M V Zacarias, V H Souza, J V Visentainer, J E L Visentainer

    This case-control study compared perinatal and laboratory factors between preterm infants who received unfortified human milk (HM) and those who received HM fortified with FM85®. The sample included 38 low birth weight (LBW) preterm infants admitted to a neonatal intensive care unit between June 2022 and May 2023, excluding those with comorbidities or formula use. Perinatal variables including gestational age, birth weight, head circumference (HC), and mode of delivery were analyzed for associations with fortifier use using chi-squared and Student's t-tests. Laboratory values were compared across nutritional stages using the Kruskal-Wallis and Mann-Whitney tests. Very preterm infants (confidence interval [CI]: 4.02-21.10; P<0.001) and those with LBW (CI: 1.30-5.75; P=0.009) were more likely to receive the fortifier, particularly those with poor weight progression during trophic feeding (CI: 1.12-16.30; P=0.039). Altered HC (CI: 1.49-8.24; P=0.004) and cesarean delivery (CI: 2.24-11.30; P<0.001) were also associated with FM85® use. Both groups showed laboratory abnormalities with neutrophils, initially elevated, decreasing (P<0.0001), while lymphocytes increased (P<0.0001). Red blood cell (P=0.00026) and hemoglobin levels (P=0.00007) worsened. Sodium and calcium levels rose significantly (P<0.0001 for both). HM fortification did not significantly alter most laboratory values, except for red blood cell count. LBW, altered HC, and cesarean delivery were associated with a greater likelihood of fortifier use. Immunological changes occurred even with fortification. Homologous fortifiers may represent a more physiological alternative.

  • Open Access

    Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population

    by Sergio Grava, Matheus Braga, Victor Hugo de Souza, Afonso Carrasco Pepineli, Aléia Harumi Uchibaba Yamanaka, Christiane Maria Ayo, Joana Maira Valentini Zacarias, Andréa Name Colado Simão, Larissa Danielle Bahls Pinto, Quirino Alves de Lima Neto, et al.

    The high variability of human leukocyte antigen (HLA) genes results in each molecule having distinct antigenic peptide binding capacities, potentially influencing the immune response to SARS-CoV-2. This study aimed to investigate associations between HLA class I (A, B) and class II (DRB1) polymorphisms and COVID-19 severity in a South Brazilian population, and to evaluate the binding affinity of alleles to viral peptides. A cross-sectional study included 503 unvaccinated patients with RT-qPCR-confirmed COVID-19: 145 non-severe, 129 severe, and 229 critical. HLA typing was performed using PCR-SSO and Luminex™ technology. The DRB1*11 allelic group was significantly associated with protection against severe and critical cases, while DRB1*15 was associated with increased risk; both remained significant after Bonferroni correction. Other allelic groups were associated with disease outcomes but lost significance after correction: B*49 and B*08 (risk); and B*37, B*50, and A*03 (protection). In silico analysis revealed that the DRB1*15 allele group showed a higher proportion of strong binders, mostly from non-structural proteins, while DRB1*11:01 binders, though fewer in number, were concentrated in the M protein. These results suggest functional differences in antigen presentation and reinforce the relevance of class II HLA, particularly DRB1, in modulating COVID-19 severity.


  • Open Access

    The Influence of Genetic Polymorphisms of IL33 and IL1RL1 Genes on the Immunopathogenesis of Periodontitis

    by Aléia Harumi Uchibaba Yamanaka, Josiane Bazzo de Alencar, Victor Hugo de Souza, Joana Maiara Valentini Zacarias, Larissa Danielle Bahls-Pinto, Cléverson O. Silva, Ana Maria Sell, Quirino Alves de Lima Neto

    Periodontitis (PD) is an inflammatory disease that affects the protective and supporting tissues of teeth. Mutations in cytokines and their receptors may influence the immunopathogenesis of PD, but the role of interleukin‐33 (IL‐33) and IL1RL1 is not clear. Thus, this study aimed to analyze the polymorphisms in IL33 (rs1929992 and rs7025417) and IL1RL1 (rs11685424 and rs3821204) genes and the IL‐33 serum levels in PD patients. A case–control study was performed with 186 PD patients and 189 controls. Genotyping was performed by polymerase chain reaction using sequence‐specific primer (PCR‐SSP) technique. Serum levels of IL‐33 were determined using the immunoenzymatic method. Statistical analyses were performed using SNPStats and OpenEpi. p > 0.05 was considered statistically significant. The IL33 rs7025417 C/C genotype was a risk factor for PD in nonsmokers ( p = 0.0015) regardless of smoking status and gender. In the general population, the IL1RL1 rs3821204 G/G genotype was protective for PD ( p = 0.006), regardless of gender. Nevertheless, the IL‐33 serum levels were increased in patients compared to controls ( p < 0.0001); however, no difference was observed among PD patients. The polymorphisms IL33 rs7025417 and IL1RL1 rs3821204 were associated with risk and protection, respectively, and the production of IL‐33 was higher in PD patients than in controls, independent of the extent or severity of the disease.

  • Open Access

    TNF-alpha and IL-17 cytokine levels in Brazilian patients with ankylosing spondylitis after anti-TNF therapy

    by Fernanda Formaggi Lara-Armi, Jeane Eliete Laguila Visentainer, Matheus Braga, Joana Maira Valentini Zacarias, Marco Antônio Rocha-Loures, Janisleya Silva Ferreira Neves, Ricardo Alberto Moliterno, Ana Maria Sell

    The aim of this study was to evaluate tumor necrosis factor alpha (TNF-α), interleukin (IL)- 17A/F levels in the serum of ankylosing spondylitis (AS) patients after anti-TNF therapy, in order to understand how these cytokines are involved in this therapeutic response. Forty-four AS patients were included in the study: thirty using anti-TNF therapy were classified according to their therapy response as responders (15) and non-responders (15) and 14 without anti-TNF therapy were classified as AS control. Fifteen healthy individuals formed the control group. Serum levels of TNF-α were determined using Luminex technology and for IL-17A and IL-17F using ELISA. The non-responder patients presented higher serum levels of TNF-α than the responders and AS control; the same results were found when HLA-B*27 positive or negative patients were separately analyzed. IL-17A and IL17F serum levels were similar for all groups. According to the clinical disease activity, AS patients with BASDAI ≥4 had higher serum levels of TNF-α than AS patients with BASDAI <4. Positive correlation was found between TNF-α levels and BASDAI. In AS patients, TNF-α serum levels were associated with anti-TNF therapy and disease activity independently of HLA-B*27, and IL-17A and IL-17F were not related to anti-TNF treatment.

  • Effect of lyophilization and spray-drying on cytokine levels and antioxidant capacity in human milk

    by Vanessa Javera Castanheira Neia, Joana Maira Valentini Zacarias, Josiane Bazzo de Alencar, Patrícia Daniele Silva dos Santos, Christyna Beatriz Genovez Tavares, Meliana G. Paula, Silvio Claudio da Costa, Mariana Maciel de Oliveira, Celso Vataru Nakamura, Oscar Oliveira Santos, et al.

    Human milk is important for modulating the newborn’s immune and antioxidant response. The applicability of lyophilization and spray-drying processes in human milk donated to human milk banks are alternatives for storage and distribution when breastfeeding is not possible. Therefore, the aim of this work was to detect and quantify cytokines (IFN-ɣ, IL-4, IL-5, IL-10, IL-13, IL-17 A/F, IL-21, and IL-22) and to evaluate the antioxidant capacity in different phases of donated HM submitted to lyophilization and spray-drying processes. The HM donated in natura was submitted to pasteurization, lyophilization and spray-drying processes, then cytokine concentrations were measured using Luminex technology and antioxidant capacity of the superoxide dismutase and catalase enzymes and reduced glutathione levels in vitro. Cytokine profiles, catalase, superoxide dismutase and reduced glutathione profiles were preserved after processing of lyophilization and spray-drying in all phases of donated human milk.


  • Open Access

    IL17F: A Possible Risk Marker for Spondyloarthritis in HLA-B*27 Negative Brazilian Patients

    by Janisleya Silva Ferreira Neves, Jeane Eliete Laguila Visentainer, Denise Manjurma da Silva Reis, Marco Antonio Rocha Loures, Hugo Vicentin Alves, Joana Maira Valentini Zacarias, Ana Maria Sell

    HLA-B*27 is an important marker for spondyloarthritis (SpA), however, many SpA patients are HLA-B*27 negative. Thus, the aim of this study was to investigate the influence of IL17, TNF and VDR gene polymorphisms in SpA patients who were HLA-B*27 negative. This case-control study was conducted in 158 patients [102 patients with ankylosing spondylitis (AS) and 56 with psoriatic arthritis (PsA)] and 184 controls. HLA-B*27 genotyping was performed using PCR-SSP and IL17A (rs2275913), IL17F (rs763780), TNF-308 (rs1800629), TNF-238 (rs361525), FokI C>T (rs2228570), TaqI C>T (rs731236), ApaI A>C (rs7975232), and BsmI C>T (rs1544410) using PCR-RFLP. Statistical analyses were performed by Chi-square and logistic regression using OpenEpi and SNPStats software. The IL17F C allele frequency was higher in patients with SpA, AS and PsA compared to controls. The IL17F T/C genotype frequency was higher in SpA patients in an overdominant inheritance model and when men and women were separately analyzed. IL17A_IL17F AC haplotype was significantly associated to the risk for SpA patients. As for VDR, the ApaI a/a was a potential risk factor for SpA in men. In conclusion, IL17F C variant contributed to the risk of SpA in Brazilian patients who were HLA-B*27 negative and could be a potential marker for SpA.


  • Open Access

    The Influence of Vitamin D Receptor Gene Polymorphisms in Spondyloarthritis

    by Janisleya Silva Ferreira Neves, Jeane Eliete Laguila Visentainer, Denise Manjurma da Silva Reis, Marco Antonio Rocha Loures, Hugo Vicentin Alves, Fernanda Formaggi Lara-Armi, Josiane Bazzo de Alencar, Joana Maira Valentin Zacarias, Ana Maria Sell

    Spondyloarthritis (SpA) is an inflammatory rheumatic disease related to low bone mineral density. Because vitamin D plays an important role in bone metabolism and immune system modulation, the aim of this study was to evaluate the influence of polymorphisms in vitamin D receptor genes (VDR) in the development of SpA. In this case–control study, a total of 244 patients with SpA and 197 individuals with no SpA were included. Among the patients, 174 had ankylosing spondylitis (AS) and 66 had psoriatic arthritis (PsA). Genotyping of FokI (rs2228570 C > T), BsmI (rs1544410 C > T), ApaI (rs7975232 A > C), and TaqI (rs731236 T > C) was performed using PCR-RFLP, while genotyping of HLA-B27 was performed using PCR-SSP. Serum levels for hydroxy (OH) vitamin D and the clinical activity index of the disease (BASDAI) were also evaluated. SNPStats and OpenEpi software were used for statistical analysis. The ApaI a allele and ApaI a/a genotype were less frequent in PsA compared with controls. The ApaI a/a genotype was associated with a protecting factor for PsA in females, and ApaI A/a was associated with a protecting factor for the disease in HLA-B27 positive patients. Notwithstanding, the ApaI a/a genotype was a risk factor for SpA and AS in males. The FokI f/f genotype was associated with a better clinical activity in PsA. When considering the covariates, vitamin D sufficiency, and gender, the FokI F/F genotype was associated with a risk factor in males with SpA and AS compared with females with this same genotype. In conclusion, the ApaI rs7975232 polymorphism was associated with PsA, and the FokI rs2228570 polymorphism was associated with better clinical PsA activity. ApaI and FokI were associated with SpA and AS when considering gender and vitamin D sufficiency.


  • Open Access

    The Influence ofTLR4,CD14,OPG, andRANKLPolymorphisms in Periodontitis: A Case-Control Study

    by Joana Maira Valentini Zacarias, Josiane Bazzo de Alencar, Patrícia Yumeko Tsuneto, Victor Hugo de Souza, Cléverson O. Silva, Jeane Eliete Laguila Visentainer, Ana Maria Sell

    The pathogenesis of periodontitis involves a complex interaction between the microbial challenge and the host immune response. The individual immunoinflammatory response has a great contribution in the pathogenesis of the disease and becomes a trigger in the process of bone remodeling which is a characteristic of the disease. Thus, the aim of this study was to evaluate the influence of theTLR4A896G (rs4986790),TLR4C1196T (rs4986791),CD14C-260T (rs2569190),RANKL(TNFSF11, rs2277438), andOPG(TNFSF11BC163T, rs3102735) polymorphisms in periodontitis. A case-control study was conducted on patients with periodontitis (N=203) and controls (N=213) over 30 years of age, without diabetes mellitus, acute infections, and osteoarthritis, and patients without aggressive periodontitis, i.e., stage IV and C degree of periodontitis, and any periodontal treatment performed in the last 6 months. Genotypes were determined by the PCR-RFLP and sequencing method. The frequency comparisons between case and controls were performed using the chi-square test and logistic regression (OpenEpi and SNPStats software). The risk (OR) was evaluated for values ofP<0.05. Differences inTLR4,CD14,RANKL, andOPGgenotype and allele frequency distributions were not observed between patients and controls. However, some variants were a risk factor for the development of periodontitis when considering gender and smoking habits. TheTLR4896 A/G genotype was a risk factor for periodontitis in males (OR=2.86), and theTLR41196C/C genotype was a risk factor for nonsmoking males (OR=1.85) when compared to women. TheRANKLA/A and theOPGT/C genotype was associated with the risk of the disease in nonsmoking men compared to nonsmoking women with the same genotype (OR=1.96andOR=2.9, respectively). In conclusion,TLR4,CD14,RANKL, andOPGvariants were not associated with periodontitis. However,TLR4,RANKL, andOPGpolymorphisms could be a risk for periodontitis in males regardless of smoking habits.


  • Open Access

    IL18 Polymorphism and Periodontitis Susceptibility, Regardless of IL12B, MMP9, and Smoking Habits

    by Patrícia Yumeko Tsuneto, Victor Hugo de Souza, Josiane Bazzo de Alencar, Joana Maira Valentini Zacarias, Cléverson O. Silva, Jeane Eliete Laguila Visentainer, Ana Maria Sell

    Genetic variations contribute to the susceptibility in the development of periodontitis. The aim of this study was to investigate the influence of IL18, IL12, and MMP9 polymorphisms in the chronic periodontitis. This case-control study involved 381 individuals matched by gender and age. Genotyping of IL18 (rs187238 and rs1946518) and IL12B (rs3212227) was performed by PCR-SSP and PCR-RFLP was used for MMP9 (rs3918242). IL-18 and MMP-9 were quantified in the serum by ELISA. SNPStats and OpenEpi software were used for statistical analysis and, in order to eliminate smoking as a confounding factor, the analyses were also performed in nonsmoking subjects. The IL18-137G/C genotype was associated with the risk of chronic periodontitis in nonsmokers (Pc=0.03; OR=1.99; overdominant inherence model). In the multivariate analyses, homozygous IL18-137G/G and IL18-607C/C were more frequent in males compared to women with these same genotypes (OR=2.51 and OR=3.30, respectively). The serum levels of the IL-18 in patients were higher than those in healthy controls (P=0.005). IL12B and MMP9 polymorphisms and MMP-9 serum concentration were similar in patients and controls. In this study, IL18 was associated with chronic periodontitis susceptibility. Men had greater risk than women for developing the disease when IL18 polymorphism was considered and the susceptibility was independent of the smoking status.